1. Albumin-based drug delivery using cysteine 34 chemical conjugates – important considerations and requirements. (July 2017) Authors: Caspersen, Mikael B; Kuhlmann, Matthias; Nicholls, Karl; Saxton, Malcolm J; Andersen, Birgitte; Bunting, Karen; Cameron, Jason; Howard, Kenneth A Journal: Therapeutic delivery Issue: Volume 8:Number 7(2017) Page Start: 511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Albumin: the next-generation delivery technology. (April 2015) Authors: Howard, Kenneth A Journal: Therapeutic delivery Issue: Volume 6:Number 3(2015) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine. (1st April 2019) Authors: Fredsøe, Jacob; Rasmussen, Anne K I; Laursen, Emma B; Cai, Yunpeng; Howard, Kenneth A; Pedersen, Bodil G; Borre, Michael; Mouritzen, Peter; Ørntoft, Torben; Sørensen, Karina D Journal: Clinical chemistry Issue: Volume 65:Number 4(2019) Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Providing the full picture: a mandate for standardizing nanoparticle-based drug delivery. (July 2013) Authors: Howard, Kenneth A; Peer, Dan Journal: Nanomedicine Issue: Volume 8:Number 7(2013) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Providing the full picture: a mandate for standardizing nanoparticle-based drug delivery. (July 2013) Authors: Howard, Kenneth A; Peer, Dan Journal: Nanomedicine Issue: Volume 8:Number 7(2013) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Providing the full picture: a mandate for standardizing nanoparticle-based drug delivery. (July 2013) Authors: Howard, Kenneth A; Peer, Dan Journal: Nanomedicine Issue: Volume 8:Number 7(2013) Page Start: 1031 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Roadmap on nanomedicine. (8th October 2020) Authors: Decuzzi, Paolo; Peer, Dan; Mascolo, Daniele Di; Palange, Anna Lisa; Manghnani, Purnima Naresh; Moghimi, S Moein; Farhangrazi, Z Shadi; Howard, Kenneth A; Rosenblum, Daniel; Liang, Tingxizi; Chen, Zhaowei; Wang, Zejun; Zhu, Jun-Jie; Gu, Zhen; Korin, Netanel; Letourneur, Didier; Chauvierre, Cédric;... Journal: Nanotechnology Issue: Volume 32:Number 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Site-selective conjugation of an anticoagulant aptamer to recombinant albumins and maintenance of neonatal Fc receptor binding. (26th April 2017) Authors: Schmøkel, Julie; Voldum, Anders; Tsakiridou, Georgia; Kuhlmann, Matthias; Cameron, Jason; Sørensen, Esben S; Wengel, Jesper; Howard, Kenneth A Journal: Nanotechnology Issue: Volume 28:Number 20(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeting the IL-6–Yap–Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis. Issue 2 (29th November 2021) Authors: Symons, Rebecca A; Colella, Fabio; Collins, Fraser L; Rafipay, Alexandra J; Kania, Karolina; McClure, Jessica J; White, Nathan; Cunningham, Iain; Ashraf, Sadaf; Hay, Elizabeth; Mackenzie, Kevin S; Howard, Kenneth A; Riemen, Anna H K; Manzo, Antonio; Clark, Susan M; Roelofs, Anke J; De Bari, Cosimo Journal: Annals of the rheumatic diseases Issue: Volume 81:Issue 2(2022) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗